|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.5000 - 0.5000|
|52 Week Range||0.3000 - 1.1000|
|Beta (3Y Monthly)||2.62|
|PE Ratio (TTM)||8.33|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Fuse Medical, Inc., (FZMD), a distributor and an emerging manufacturer of medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2019, with the United States Securities and Exchange Commission, on Tuesday, May 7, 2019. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to announce improvements in our first quarter of 2019 results, with an eleven (11) percentage point increase to gross profit and one (1) percentage point improvement in earnings, as a percentage of net revenues, compared to the same period one year ago. The filing can be found on the Company’s website at http://www.fusemedical.com/investors.
Fuse Medical, Inc., , an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018.
Fuse Medical, Inc., , , announced that OTC Markets has identified Fuse as “Penny Stock Exempt,” meaning that shares of Fuse’s common stock, par value $0.01 per share , is no longer a “Penny Stock” as defined in Rule 3a51-1, promulgated under the Securities Exchange Act of 1934, as amended.
Fuse Medical, Inc., , , a contract manufacturer and national distributor of medical devices, announced that it has been named Number 56 on the Deloitte’s 2018 Technology Fast 500TM , an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life sciences and energy tech sectors.
Fuse Medical, Inc., , , announced that it has filed its quarterly report on Form 10-Q for the third quarter ended September 30, 2018 of the Fiscal Year 2018 with the United States Securities and Exchange Commission, on Tuesday November 13, 2018.
Fuse Medical, Inc. , announced the completion of the acquisition of Palm Springs Partners, LLC d/b/a Maxim Surgical , a manufacturing company in the spinal fusion device market and full-service medical device and distribution company .